Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer

This publication has 11 references indexed in Scilit:

• Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany.
  Cancer Investigation, 2001
• Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck
  JNCI Journal of the National Cancer Institute, 1996
• Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.
  Journal of Clinical Oncology, 1993
• Effect of the Radioprotector WR2721 on Irradiation-Induced Injury to Ciliated Cells of Eustachian Tube
  Annals of Otology, Rhinology & Laryngology, 1992
• Long-term effects of radioprotector WR-2721 on locomotor activity and body weight of mice following exposure to ionizing radiation
  Toxicology, 1988
• Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injury
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Combined radiosensitization and radioprotection for oral cavity tumors: Study with an oral cavity tumor model
  International Journal of Radiation Oncology*Biology*Physics, 1982
• Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole
  The British Journal of Radiology, 1981
• Radioprotection of oral cavity structures by wr-2721
  International Journal of Radiation Oncology*Biology*Physics, 1978